Fred B.  Davenport, Jr. net worth and biography

Fred Davenport, Jr. Biography and Net Worth

Director of Medpace

Mr. Davenport is a partner at the law firm of Murchison, Taylor & Gibson, PLLC and focuses his practice on mergers and acquisitions, general corporate representation and estate planning. He previously served as President of Pharmaceutical Product Development, Inc. (“PPD”) from 2002 to 2006. From 2001 to 2002, Mr. Davenport was Executive Vice President of PPD and from 1996 to 2001 he was General Counsel of PPD. Prior to joining PPD, Mr. Davenport practiced at Murchison, Taylor & Gibson, PLLC as an associate from 1977 to 1980 and as a partner from 1981 to 1996, which included acting as the managing partner from 1991 to 1995. Mr. Davenport has also served on the faculty of the Cameron School of Business as a tenured professor. From 2015 to March 2016, Mr. Davenport was a Director of Clinipace Worldwide and from 2009 to 2011 he was a Director of Medex Global Group, Inc. Additionally, Mr. Davenport was a Director of predecessor entities of the Company from 2007 to 2013. Mr. Davenport has also served on numerous community and non-profit boards.

Mr. Davenport received his Bachelor’s Degree, MBA and JD from the University of North Carolina at Chapel Hill. Mr. Davenport was chosen as a director because of his significant experience in the CRO industry, his experience as an executive and his experience serving on boards.

What is Fred B. Davenport, Jr.'s net worth?

The estimated net worth of Fred B. Davenport, Jr. is at least $886,718.46 as of April 24th, 2025. Mr. Davenport, Jr. owns 2,998 shares of Medpace stock worth more than $886,718 as of May 21st. This net worth estimate does not reflect any other investments that Mr. Davenport, Jr. may own. Learn More about Fred B. Davenport, Jr.'s net worth.

How do I contact Fred B. Davenport, Jr.?

The corporate mailing address for Mr. Davenport, Jr. and other Medpace executives is 5375 MEDPACE WAY, CINCINNATI OH, 45227. Medpace can also be reached via phone at (513) 579-9911 and via email at investor@medpace.com. Learn More on Fred B. Davenport, Jr.'s contact information.

Has Fred B. Davenport, Jr. been buying or selling shares of Medpace?

During the last quarter, Fred B. Davenport, Jr. has sold $516,715.84 of Medpace stock. Most recently, Fred B. Davenport, Jr. sold 1,712 shares of the business's stock in a transaction on Thursday, April 24th. The shares were sold at an average price of $301.82, for a transaction totalling $516,715.84. Following the completion of the sale, the director now directly owns 2,998 shares of the company's stock, valued at $904,856.36. Learn More on Fred B. Davenport, Jr.'s trading history.

Who are Medpace's active insiders?

Medpace's insider roster includes Kevin Brady (CFO), Susan Burwig (VP), Fred Davenport, Jr. (Director), Stephen Ewald (General Counsel), Jesse Geiger (CFO), Ashley Keating (Director), Tom King (Director), Robert Kraft (Director), and August Troendle (CEO). Learn More on Medpace's active insiders.

Are insiders buying or selling shares of Medpace?

In the last twelve months, Medpace insiders bought shares 1 times. They purchased a total of 2 shares worth more than $652.22. In the last twelve months, insiders at the sold shares 4 times. They sold a total of 11,449 shares worth more than $4,366,773.53. The most recent insider tranaction occured on April, 24th when Director Fred B Davenport Jr sold 1,712 shares worth more than $516,715.84. Insiders at Medpace own 20.3% of the company. Learn More about insider trades at Medpace.

Information on this page was last updated on 4/24/2025.

Fred B. Davenport, Jr. Insider Trading History at Medpace

See Full Table

Fred B. Davenport, Jr. Buying and Selling Activity at Medpace

This chart shows Fred B Davenport Jr's buying and selling at Medpace by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$517ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$400k-$200k$0$200k$400kTotal Insider BuyingTotal Insider Selling

Medpace Company Overview

Medpace logo
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Read More

Today's Range

Now: $295.77
Low: $292.53
High: $303.41

50 Day Range

MA: $303.06
Low: $277.23
High: $330.59

2 Week Range

Now: $295.77
Low: $250.05
High: $459.77

Volume

371,065 shs

Average Volume

350,497 shs

Market Capitalization

$8.50 billion

P/E Ratio

23.42

Dividend Yield

N/A

Beta

1.55